Literature DB >> 9633001

Antiretroviral therapy: where are we?

S M Hammer1, P Yeni.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9633001

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  3 in total

1.  Efficacy, individual effectiveness, and population effectiveness in substance abuse treatment.

Authors:  G E Woody; A Muñoz
Journal:  Curr Psychiatry Rep       Date:  2000-12       Impact factor: 5.285

2.  Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA.

Authors:  G P Rizzardi; R J De Boer; S Hoover; G Tambussi; A Chapuis; N Halkic; P A Bart; V Miller; S Staszewski; D W Notermans; L Perrin; C H Fox; J M Lange; A Lazzarin; G Pantaleo
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

3.  Monitoring resistance to human immunodeficiency virus type 1 protease inhibitors by pyrosequencing.

Authors:  D O'Meara; K Wilbe; T Leitner; B Hejdeman; J Albert; J Lundeberg
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.